Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004499

Chief Executive Officer sold 34,435 shares at $5.08 ($174,851)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-19 Sale : show line 1 in the form −34,435 $5.08 $174,851 601,607 D
Open-market sales · 34,435 sh · avg $5.08 · $174,851
Loading xslF345X03/doc4.xml…